Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs?
If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs?
If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs?
Submitted by
admin
on July 11, 2014 - 11:10am
Source:
Forbes
News Tags:
R&D
antibiotics
superbugs
antibiotic resistance
Headline:
If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs?
Do Not Allow Advertisers to Use My Personal information
